Abstract
RECENT reviews1–3 on the treatment of Trypanosoma cruzi infections (Chagas's disease, South American trypanosomiasis) in man emphasize the lack of a satisfactory mode of therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
World Health Org. Tech. Rep. Ser. No. 202 (Geneva, 1960).
Kollert, W., Clinical Excerpts, 26, 89 (June, 1960) (Bayer, Leverkusen, Germany).
Hawking, F., in Experimental Chemotherapy, edit. by Schnitzer, R. J., and Hawking, F., 1, 129 (Academic Press, New York, 1963).
Hewitt, R., Entwistle, J., and Gill, E., J. Parasit., 49, 22 (1963).
Pizzi, T., Proc. Soc. Exp. Biol. and Med., 78, 643 (1951).
Moraes, G. E. S., Faria, J. L., and Fernandes, J. F., Rev. Inst. Med. trop. Sao Paulo, 2, 147 (1960).
Moon, A. P., and Coleman, J. F., Bol. Chil. Parasit., 17, 63 (1962).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
TOMCUFCIK, A., HEWITT, R., FABIO, P. et al. N4-substituted N1-(3-Dimethylaminopropyl)-piperazines : a New Series of Compounds active against Trypanosoma cruzi Infections in Mice. Nature 205, 605–606 (1965). https://doi.org/10.1038/205605b0
Issue date:
DOI: https://doi.org/10.1038/205605b0
